Sofimac Investment Managers is a venture capital firm that provides financial support to SMEs for medium- and long-term development.
Business Model:
Revenue: $13.7M
Employees: 2-10
Address: 24 avenue of Agriculture
City: Clermont-Ferrand
State: auvergne
Zip: 63100
Country: FR
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefs d’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2017 | Woom GmbH | Seed Round | 300k |
8/2015 | Bulane | Series A | 2.7M |
12/2012 | Laboratoires Cyclopharma SA | Venture Round | - |
11/2016 | Advanced Perfusion Diagnostics | Series A | 3M |
5/2013 | Effidence | Venture Round | - |
6/2013 | INDATECH - Chauvin Arnoux Group | Venture Round | 600k |
1/2013 | METHAJOULE | Seed Round | - |
5/2016 | Arioneo | Seed Round | 1.2M |
1/2020 | Snowleader | Venture Round | 0 |
3/2016 | SA Galalitum | Venture Round | 198.3k |
3/2015 | ADDIPLAST Sas | Venture Round | - |
9/2013 | Perfect Memory | Seed Round | 600k |
10/2016 | Glomeria Therapeutics | Grant | 3.2M |
7/2013 | Alpwise | Private Equity Round | 979.5k |
11/2016 | Aston Medical | Seed Round | 264.8k |
3/2009 | IPM France | Venture Round | 1.3M |
7/2014 | ISORG | Venture Round | 8.7M |
1/2010 | Glycode | Series B | 4.3M |
5/2013 | ElsaLys Biotech | Series A | 0 |
4/2012 | Jet Metal Technologies | Venture Round | 1.7M |
4/2015 | APTE SA | Venture Round | - |
10/2013 | Lytess | Venture Round | - |
7/2010 | Allegorithmic | Series B | 1.9M |
11/2010 | ExoTIC Systems | Venture Round | - |
9/2016 | Tunetoo | Venture Round | 1.1M |
12/2014 | BioFilm Control | Venture Round | 3.7M |
11/2014 | Theranexus | Seed Round | 4.5M |
12/2018 | Blue Valet | Venture Round | 0 |
4/2018 | Ideol Offshore | Venture Round | 0 |
4/2018 | Uavia | Seed Round | 0 |
4/2018 | Eurekam | Venture Round | 1.8M |
3/2015 | Amolyt Pharma | Venture Round | 1.9M |
9/2011 | Laboratoire Precilens | Venture Round | 4.1M |
1/2008 | XL Group | Post-IPO Equity | 1.5M |
1/2011 | CenterVue SpA | Private Equity Round | - |
9/2014 | Primo1D | Venture Round | 3.9M |
3/2017 | Whisperies | Seed Round | 609.4k |
3/2015 | Search&s;XPR Inc. | Venture Round | 2.1M |
10/2010 | CellMade | Funding Round | 2.3M |
9/2017 | Diabeloop | Series A | 0 |
4/2020 | Mob-Energy | Seed Round | 0 |
2/2014 | Microphyt | Private Equity Round | 2.8M |
12/2016 | Aston - SEM (Groupe Acropole) | Seed Round | 268k |
1/2011 | Filedanstachambre | Venture Round | 1.1M |
12/2013 | Axess Vision Technology | Series B | 0 |
5/2016 | Ixaltis | Venture Round | 8M |
10/2012 | Biom&s;Up | Series B | 0 |
10/2018 | Bulane | Series B | - |
2/2017 | Care Labs | Series A | 0 |
11/2007 | Wirecom Technologies | Series B | 5.8M |
1/2013 | CNSE S.A.S. | Venture Round | - |
1/2011 | Brea System SAS | Venture Round | - |
3/2014 | Cosmo Tech | Series A | 5.2M |
6/2017 | Cosmo Tech | Convertible Note | 3.3M |
3/2016 | FineHeart | Series A | 7.2M |
7/2016 | eLichens | Venture Round | 0 |
11/2015 | Advanced Perfusion Diagnostics | Seed Round | 1.7M |
5/2016 | Ideol Offshore | Venture Round | 3.4M |
1/2006 | METabolic EXplorer | Series C | 6.1M |
11/2000 | METabolic EXplorer | Series A | 1.3M |
1/2013 | Eydo Pharma | Venture Round | - |
4/2012 | AREM | Venture Round | 1.3M |
9/2005 | EFFEMINS GROUP | Venture Round | - |
4/2014 | Echodia S.A.S | Seed Round | 550.6k |
7/2013 | Aciers Coste SA | Venture Round | - |
3/2009 | Aptys Pharmaceuticals SAS, | Venture Round | - |
4/2017 | Blue Valet | Venture Round | 2M |
1/2014 | Groupe Villemain | Venture Round | - |
2/2016 | AFYREN | Venture Round | 556.3k |
6/2011 | Danesi Industries | Venture Round | - |
5/2000 | Graitec | Series A | - |
3/2016 | Valbiotis | Seed Round | 2M |
4/2020 | Mob-Energy | Seed Round | 0 |
1/2020 | Snowleader | Venture Round | 0 |
12/2018 | Blue Valet | Venture Round | 0 |
10/2018 | Bulane | Series B | - |
4/2018 | Ideol Offshore | Venture Round | 0 |
4/2018 | Uavia | Seed Round | 0 |
4/2018 | Eurekam | Venture Round | 0 |
9/2017 | Diabeloop | Series A | 0 |
9/2017 | Woom GmbH | Seed Round | 0 |
6/2017 | Cosmo Tech | Convertible Note | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|